ARCHIVES

The Clinical Cancer Letter To End Print Edition In 2010

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

Board Defers core Guideline changes, Asks Subcommittee For Alternate Plans

November 18, 1977

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

Cancer Education: NCI Offers Training In Epidemiology And Genetics

April 17, 1998

John Niederhuber Named Acting NCI Director.

June 2, 2006

Biotech Organization Endorses Measures On Orphan Drug Act

April 1, 1994

Cancer Center In Russia Seeks Cancer Drugs, Other Supplies, From US

July 30, 1993